Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
603
-
Total shares
-
76.3M
-
Shares change
-
-14.7M
-
Total reported value, excl. options
-
$11.9B
-
Value change
-
-$2.29B
-
Put/Call ratio
-
1.99
-
Number of buys
-
206
-
Number of sells
-
-300
-
Price
-
$156.38
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q4 2017
621 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q4 2017.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 603 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.3M shares
of 80.8M outstanding shares and own 94.36% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (9.1M shares), BlackRock Inc. (6.89M shares), BAMCO INC /NY/ (4.7M shares), Fundsmith LLP (4.4M shares), STATE STREET CORP (3.71M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.07M shares), RENAISSANCE TECHNOLOGIES LLC (1.88M shares), BLAIR WILLIAM & CO/IL (1.78M shares), Neuberger Berman Group LLC (1.65M shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1.25M shares).
This table shows the top 603 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.